Legis Daily

LAB Act

USA116th CongressS-3049| Senate 
| Updated: 12/12/2019
Sherrod Brown

Sherrod Brown

Democratic Senator

Ohio

Cosponsors (5)
Thomas Tillis (Republican)Michael F. Bennet (Democratic)Pat Roberts (Republican)Robert Menendez (Democratic)Richard Burr (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Laboratory Access for Beneficiaries Act or the LAB Act This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 28, 2019

Latest Companion Bill Action

HR 116-3584
Referred to the Subcommittee on Health.
Dec 12, 2019
Introduced in Senate
Dec 12, 2019
Read twice and referred to the Committee on Finance.
  • June 28, 2019

    Latest Companion Bill Action

    HR 116-3584
    Referred to the Subcommittee on Health.


  • December 12, 2019
    Introduced in Senate


  • December 12, 2019
    Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 116-1865: Further Consolidated Appropriations Act, 2020
  • HR 116-3584: LAB Act
Congressional oversightDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth information and medical recordsInflation and pricesMedical tests and diagnostic methodsMedicare

LAB Act

USA116th CongressS-3049| Senate 
| Updated: 12/12/2019
Laboratory Access for Beneficiaries Act or the LAB Act This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 28, 2019

Latest Companion Bill Action

HR 116-3584
Referred to the Subcommittee on Health.
Dec 12, 2019
Introduced in Senate
Dec 12, 2019
Read twice and referred to the Committee on Finance.
  • June 28, 2019

    Latest Companion Bill Action

    HR 116-3584
    Referred to the Subcommittee on Health.


  • December 12, 2019
    Introduced in Senate


  • December 12, 2019
    Read twice and referred to the Committee on Finance.
Sherrod Brown

Sherrod Brown

Democratic Senator

Ohio

Cosponsors (5)
Thomas Tillis (Republican)Michael F. Bennet (Democratic)Pat Roberts (Republican)Robert Menendez (Democratic)Richard Burr (Republican)

Finance Committee

Health

Related Bills

  • HR 116-1865: Further Consolidated Appropriations Act, 2020
  • HR 116-3584: LAB Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth information and medical recordsInflation and pricesMedical tests and diagnostic methodsMedicare